Merck Other Long-Term Assets 2010-2024 | MKKGY
Merck other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Merck other long-term assets for the quarter ending June 30, 2024 were $0.144B, a 50.39% increase year-over-year.
- Merck other long-term assets for 2023 were $0.124B, a 19.33% increase from 2022.
- Merck other long-term assets for 2022 were $0.104B, a 7.2% decline from 2021.
- Merck other long-term assets for 2021 were $0.112B, a 88.03% decline from 2020.
Merck Annual Other Long-Term Assets
(Millions of US $) |
| 2023 |
$124 |
| 2022 |
$104 |
| 2021 |
$112 |
| 2020 |
$939 |
| 2019 |
$109 |
| 2018 |
$163 |
| 2017 |
$232 |
| 2016 |
$145 |
| 2015 |
$142 |
| 2014 |
$75 |
| 2013 |
$140 |
| 2012 |
$97 |
| 2011 |
$160 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Other Long-Term Assets
(Millions of US $) |
| 2024-06-30 |
$144 |
| 2024-03-31 |
$150 |
| 2023-12-31 |
$124 |
| 2023-09-30 |
$104 |
| 2023-06-30 |
$96 |
| 2023-03-31 |
$107 |
| 2022-12-31 |
$104 |
| 2022-09-30 |
$105 |
| 2022-06-30 |
$105 |
| 2022-03-31 |
$118 |
| 2021-12-31 |
$112 |
| 2021-09-30 |
$100 |
| 2021-06-30 |
$105 |
| 2021-03-31 |
$102 |
| 2020-12-31 |
$939 |
| 2020-09-30 |
$767 |
| 2020-06-30 |
$99 |
| 2020-03-31 |
$104 |
| 2019-12-31 |
$109 |
| 2019-09-30 |
$99 |
| 2019-06-30 |
$99 |
| 2019-03-31 |
$92 |
| 2018-12-31 |
$163 |
| 2018-09-30 |
$177 |
| 2018-06-30 |
$187 |
| 2018-03-31 |
$243 |
| 2017-12-31 |
$232 |
| 2017-09-30 |
$165 |
| 2017-06-30 |
$154 |
| 2017-03-31 |
$135 |
| 2016-12-31 |
$145 |
| 2016-09-30 |
$141 |
| 2016-06-30 |
$142 |
| 2016-03-31 |
$150 |
| 2015-12-31 |
$142 |
| 2015-09-30 |
$70 |
| 2015-06-30 |
$60 |
| 2015-03-31 |
$65 |
| 2014-12-31 |
$75 |
| 2014-09-30 |
$95 |
| 2014-06-30 |
$106 |
| 2014-03-31 |
$126 |
| 2013-12-31 |
$140 |
| 2013-09-30 |
$126 |
| 2013-06-30 |
$108 |
| 2013-03-31 |
$91 |
| 2012-12-31 |
$97 |
| 2012-09-30 |
$200 |
| 2012-06-30 |
$153 |
| 2012-03-31 |
|
| 2011-12-31 |
$160 |
| 2011-09-30 |
|
| 2011-06-30 |
$612 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$605 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
